| Dr Alfred Ngaw, PHARMD | |
|
333 Lakeside Dr, Foster City, CA 94404-1147 | |
| (800) 445-3235 | |
| Not Available |
| Full Name | Dr Alfred Ngaw |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 333 Lakeside Dr, Foster City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558469387 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 57170 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alfred Ngaw, PHARMD 333 Lakeside Dr, Foster City, CA 94404-1147 Ph: () - | Dr Alfred Ngaw, PHARMD 333 Lakeside Dr, Foster City, CA 94404-1147 Ph: (800) 445-3235 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today the presentation of clinical results for its biologic oncology candidates, lipegfilgrastim and balugrastim, at the Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) 2012 International Symposium on Supportive Care in Cancer being held in New York June 28-30.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today that new preclinical data published in the online edition of Circulation Research suggests that microRNA-15 (miR-15) inhibits cardiomyogenesis, the process whereby new heart muscle cells are formed.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles, and Cellectis plant sciences, a US-based subsidiary of Cellectis Group, the specialist in genome engineering, today announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants.
Johns Hopkins scientists have launched a pioneering research program to create, for the first time, human platelet cells from stem cells in order to study inherited blood clotting abnormalities ranging from clots that cause heart attacks and stroke to bleeding disorders.
› Verified 7 days ago
Rachel Borst, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Bridgepointe Pkwy, Foster City, CA 94404 Phone: 650-393-2126 | |
Laemsing Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Bridgepointe Pkwy, Foster City, CA 94404 Phone: 650-393-2126 | |
Michele Bell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 919 Edgewater Blvd, Foster City, CA 94404 Phone: 650-572-1167 | |
Grace Yip, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Metro Center Blvd, Foster City, CA 94404 Phone: 650-286-0759 Fax: 650-918-2059 | |
Mr. Harry Lew, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Metro Center Blvd, Foster City, CA 94404 Phone: 650-286-0759 Fax: 650-918-2059 | |
Dan Do, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 987 E Hillsdale Blvd, Foster City, CA 94404 Phone: 650-570-4693 | |
Azadeh Azad, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1030 Pizarro Ln, Foster City, CA 94404 Phone: 650-762-4353 |